Compare AFLAC Incorporated (AFL) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AFLAC Incorporated vs Amylx Pharmaceuticals Inc — how do they compare? AFLAC Incorporated trades at $121.06 (market cap $60.70B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: AFLAC Incorporated is far larger — about 23× Amylx Pharmaceuticals Inc's market cap, and AFLAC Incorporated pays a 2.02% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AFL | AMLX | |
|---|---|---|
Market Cap | $60.70B | $2.64B |
Sector | Financials | Health |
52-Week High | $129.55 | $24.19 |
52-Week Low | $103.55 | $7.82 |
Enterprise Value | $70.65B | $2.39B |
Dividend Yield | 2.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.
Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
